Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference

globenewswire.com
VOR Vor Bio is scheduled to participate in the 2026 Jefferies Global Healthcare Conference. This is a routine corporate event and does not inherently suggest positive or negative performance.

Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will provide a corporate update in a fireside chat at the Jefferies Global Healthcare Conference in New York, NY.

Presentation: Wednesday, June 3, 2026 at 9:55am – 10:25 am ET

A live webcast of the presentation may be accessed on the Investors section of the Vor website at ir.vorbio.com. A replay of the webcast will be available on the Vor website for approximately 30 days following the presentation.

About Vor Bio

Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. For more information visit www.vorbio.com.